Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Evidence",
"id" : "367908",
"meta" : {
"versionId" : "26",
"lastUpdated" : "2025-08-18T13:22:42.074Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Evidence 367908</b></p><a name=\"367908\"> </a><a name=\"hc367908\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 26; Last updated: 2025-08-18 13:22:42+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-non-comparative-evidence.html\">NonComparativeEvidence</a></p></div><p><b>ArtifactPublicationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}\">Active</span></p><p><b>url</b>: <a href=\"https://fevir.net/resources/Evidence/367908\">https://fevir.net/resources/Evidence/367908</a></p><p><b>identifier</b>: FEvIR Object Identifier/367908, FEvIR Linking Identifier/NCT03640312-secondaryOutcomeMeasure-1--OG001</p><p><b>name</b>: NCT03640312_secondaryOutcomeMeasure_1_OG001</p><p><b>title</b>: Change in Mean Diastolic Blood Pressure at 6 weeks for Candesartan in NCT03640312</p><p><b>citeAs</b>: </p><div><p>Change in Mean Diastolic Blood Pressure at 6 weeks for Candesartan in NCT03640312 [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367908. Revised 2025-08-18. Available at: https://fevir.net/resources/Evidence/367908. Computable resource at: https://fevir.net/resources/Evidence/367908#json.</p>\n</div><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>description</b>: </p><div><p>This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><blockquote><p><b>variableDefinition</b></p><p><b>description</b>: </p><div><p>Candesartan</p>\n</div><p><b>note</b>: , </p><blockquote><div><p>Outcome Measure Population Description: Modified intent to treat whereby all those participants with data at any follow-up time point and baseline to contribute to analyses will be included in analyses according to arm to which they were randomized, regardless of adherence to the study protocol.</p>\n</div></blockquote><blockquote><div><p>Outcome Measure Denominator Units: Participants</p>\n</div></blockquote><p><b>variableRole</b>: Population</p><p><b>observed</b>: Patients randomized to the comparison arm took a once daily 8mg candesartan.\n\nCandesartan: Standard monotherapy of 8mg candesartan. Taken once daily for 12 weeks. (Identifier: ClinicalTrials.gov Outcome Measurement Group Id/OG001)</p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: <a href=\"EvidenceVariable-367884.html\">Change in Mean Diastolic Blood Pressure at 6 weeks - (NCT03640312)</a></p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:\">Least Squares Mean</span></p><p><b>quantity</b>: -6.74 mm Hg</p><h3>SampleSizes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>KnownDataCount</b></td></tr><tr><td style=\"display: none\">*</td><td>30</td></tr></table><h3>AttributeEstimates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Range</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:\">95% Confidence Interval</span></td><td>-9.5--3.98 mm Hg</td></tr></table></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code" : "active",
"display" : "Active"
}
]
}
}
],
"url" : "https://fevir.net/resources/Evidence/367908",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "367908",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
{
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03640312-secondaryOutcomeMeasure-1--OG001",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "NCT03640312_secondaryOutcomeMeasure_1_OG001",
"title" : "Change in Mean Diastolic Blood Pressure at 6 weeks for Candesartan in NCT03640312",
"citeAs" : "Change in Mean Diastolic Blood Pressure at 6 weeks for Candesartan in NCT03640312 [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367908. Revised 2025-08-18. Available at: https://fevir.net/resources/Evidence/367908. Computable resource at: https://fevir.net/resources/Evidence/367908#json.",
"status" : "active",
"author" : [
{
"name" : "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
],
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"description" : "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"variableDefinition" : [
{
"description" : "Candesartan",
"note" : [
{
"text" : "Outcome Measure Population Description: Modified intent to treat whereby all those participants with data at any follow-up time point and baseline to contribute to analyses will be included in analyses according to arm to which they were randomized, regardless of adherence to the study protocol."
},
{
"text" : "Outcome Measure Denominator Units: Participants"
}
],
"variableRole" : "population",
"observed" : {
"identifier" : {
"type" : {
"text" : "ClinicalTrials.gov Outcome Measurement Group Id"
},
"value" : "OG001"
},
"display" : "Patients randomized to the comparison arm took a once daily 8mg candesartan.\n\nCandesartan: Standard monotherapy of 8mg candesartan. Taken once daily for 12 weeks."
}
},
{
"variableRole" : "outcome",
"observed" : {
🔗 "reference" : "EvidenceVariable/367884",
"type" : "EvidenceVariable",
"identifier" : {
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03640312-secondaryOutcome-1",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
"display" : "Change in Mean Diastolic Blood Pressure at 6 weeks - (NCT03640312)"
}
}
],
"statistic" : [
{
"statisticType" : {
"text" : "Least Squares Mean"
},
"quantity" : {
"value" : -6.74,
"unit" : "mm Hg"
},
"sampleSize" : {
"knownDataCount" : 30
},
"attributeEstimate" : [
{
"type" : {
"text" : "95% Confidence Interval"
},
"range" : {
"low" : {
"value" : -9.5,
"unit" : "mm Hg"
},
"high" : {
"value" : -3.98,
"unit" : "mm Hg"
}
}
}
]
}
]
}